Funding Opportunity PAR-25-099 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.

Funding Opportunity PAR-25-374 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.

Funding Opportunity RFA-EY-25-002 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to request applications that aim to implement and evaluate multi-level interventions and community engaged research in advancing vision equity. This Notice of Funding Opportunity (NOFO) supports research directed at preventing, reducing, or eliminating disparities in eye and vision health. Applications responding to this NOFO must involve multilevel interventions that simultaneously address vision health conditions and social determinants of health (SDOH) at one or more levels of influence, such as individual, interpersonal, organizational, and community. Research must include a focus on improving vision health in one or more NIH-designated Populations with Health Disparities. Additionally, research must demonstrate meaningful community engagement in the research process.

Funding Opportunity PAR-25-101 from the NIH Guide for Grants and Contracts. The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

Notice NOT-AG-24-086 from the NIH Guide for Grants and Contracts

Competitive: Kemio Consulting: 23rd December, 2024 Senior Bioinformatician - Bacterial genomics Cambridge - 3 days onsite Are you experienced working with Microbial genomic dat Cambridgeshire, United Kingdom

Competitive: Kemio Consulting: 18th December, 2024 Bioinformatician (Can consider Senior Bioinformatician) Cambridge - 3 days onsite Are you experienced working with Microbial Cambridgeshire, United Kingdom

GBP 41,607.00 - 48,224.00 per year: The Institute Of Cancer Research: Key Information Salary: £41,607* to £48,224 Dependent on relevant Postdoctoral experience. Future progression is based on annual performance review. London, United Kingdom

GBP 53,717.00 - 63,500.00 per year: Wellcome Sanger Institute: Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing scie Cambridgeshire, United Kingdom

Competitive: Manchester University NHS Foundation Trust: Job summary We are seeking a state registered Clinical Scientist Bioinformatics (Genomics) or an STP trainee graduating this year to join our team in Manchester, United Kingdom

£37,472 - £45,622 per annum: Barts Cancer Institute , Queen Mary University London: About the Role A fully funded Postdoctoral Research Assistant position is available to join a team led by Prof Susana Godinho to study how amplified London, United Kingdom

From £51,300 with benefits, subject to skills and experience: The Francis Crick Institute: In this position, you will play a key role in providing Francis Crick research groups with access to statistical expertise. London (Central), London (Greater)

Competitive: Illumina, Inc.: What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we are expanding access to genomic tec Cambridge, United Kingdom

Notice NOT-MH-25-050 from the NIH Guide for Grants and Contracts

Notice NOT-MH-25-045 from the NIH Guide for Grants and Contracts

Competitive and commensurate with experience: Department of Biomedical Informatics, HMS: The Department of Biomedical Informatics at Harvard Medical School invites applications for a tenure-track Assistant Professor position focused on ... Boston, Massachusetts (US)

Notice NOT-GM-25-017 from the NIH Guide for Grants and Contracts

Notice NOT-GM-25-016 from the NIH Guide for Grants and Contracts

Notice NOT-AA-25-002 from the NIH Guide for Grants and Contracts

€2,684.10 gross monthly (following the recommendations of FWF): CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences: The next PhD Program at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna... Vienna, Austria